South Texas Accelerated Research Therapeutics

South Texas Accelerated Research Therapeutics (START) utilizes high-quality and innovative information technology infrastructure to guide clinical trials of novel anti-cancer drugs, ensuring accurate and rapid clinical trials are conducted in an environment that emphasizes personalized and compassionate clinical care. START's mission is to accelerate the development of new anti-cancer drugs and improve the quality of life and survival rates for cancer patients.